Jukka Kero

5.0k total citations · 2 hit papers
53 papers, 3.4k citations indexed

About

Jukka Kero is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Jukka Kero has authored 53 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 20 papers in Endocrinology, Diabetes and Metabolism and 17 papers in Molecular Biology. Recurrent topics in Jukka Kero's work include Thyroid Disorders and Treatments (13 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (9 papers) and Growth Hormone and Insulin-like Growth Factors (8 papers). Jukka Kero is often cited by papers focused on Thyroid Disorders and Treatments (13 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (9 papers) and Growth Hormone and Insulin-like Growth Factors (8 papers). Jukka Kero collaborates with scholars based in Finland, United States and Germany. Jukka Kero's co-authors include Stefan Offermanns, Ilpo Huhtaniemi, Sorin Tunaru, Klaus Pfeffer, Andree Blaukat, Andreas Gille, Erika Isolauri, Elina Hemminki, Mika Gissler and Martina Lukasova and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Jukka Kero

52 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect

2003 630 citations Jukka Kero, Stefan Offermanns et al. profile →
(d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G

2005 529 citations Andrew K.P. Taggart, Jukka Kero et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Jukka Kero

Since Specialization

Citations

This map shows the geographic impact of Jukka Kero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jukka Kero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jukka Kero more than expected).

Fields of papers citing papers by Jukka Kero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jukka Kero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jukka Kero. The network helps show where Jukka Kero may publish in the future.

Co-authorship network of co-authors of Jukka Kero

This figure shows the co-authorship network connecting the top 25 collaborators of Jukka Kero. A scholar is included among the top collaborators of Jukka Kero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jukka Kero. Jukka Kero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Altered Glucagon Response to Oral Glucose in Individuals at Different Stages of Type 1 Diabetes Development 2025 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), Luís Crisóstomo, Eliisa Löyttyniemi, Jaakko J. Koskenniemi, Riitta Veijola, Jorma Toppari, Jukka Kero	1
2	Higher initial levothyroxine doses and very early treatment start may lead to better cognitive outcomes in children with congenital hypothyroidism 2024 ·Acta Paediatrica ·(unknown), (unknown), (unknown), Hanna Huopio, (unknown), Jukka Kero, Jarmo Jääskeläinen, Harri Niinikoski	1
3	Activation of mitogen-activated protein kinase signaling and development of papillary thyroid carcinoma in thyroid-stimulating hormone receptor D633H knockin mice 2023 ·European Thyroid Journal ·Markus Eszlinger, (unknown), (unknown), (unknown), Michael F. Moran, Moosa Khalil, Jukka Kero, Ralf Paschke	3
4	Treatment of Congenital Hypothyroidism: Impact of Secular Changes in Levothyroxine Initial Dose on Early Growth 2022 ·Hormone Research in Paediatrics ·(unknown), (unknown), (unknown), Jukka Kero, Hanna Huopio, Jarmo Jääskeläinen, Harri Niinikoski	5
5	INnoVative trial design for testing the Efficacy, Safety and Tolerability of 6‐month treatment with incretin‐based therapy to prevent type 1 DIAbetes in autoantibody positive participants: A protocol for three parallel double‐blind, randomised controlled trials (INVESTDIA) 2022 ·Diabetic Medicine ·Jukka Kero, Jaakko J. Koskenniemi, (unknown), Tytti Pokka, Olivia Lou, Jorma Toppari, Riitta Veijola	2
6	Exploring Minimally Invasive Approach to Define Stages of Type 1 Diabetes Remotely 2022 ·Diabetes Technology & Therapeutics ·(unknown), (unknown), Jaakko J. Koskenniemi, Eliisa Löyttyniemi, (unknown), Mikael Knip, Riitta Veijola, Jorma Toppari, Jukka Kero	7
7	Incidence of primary congenital hypothyroidism over 24 years in Finland 2022 ·Pediatric Research ·(unknown), (unknown), Hanna Huopio, Harri Niinikoski, (unknown), Jukka Kero, Jarmo Jääskeläinen	11
8	Tissue architecture delineates field cancerization in BRAFV600E-induced tumor development 2021 ·Disease Models & Mechanisms ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Therese Carlsson, Mikael Montelius, (unknown), Jukka Kero, Kajsa Paulsson, Henrik Fagman, Martin O. Bergö, Mikael Nilsson	3
9	Increased Anaplastic Lymphoma Kinase Activity Induces a Poorly Differentiated Thyroid Carcinoma in Mice 2019 ·Thyroid ·Hannah Dinse, (unknown), Georg Sebastian Hönes, Sarah Theurer, Xiao-Hui Liao, Sandra Christoph, Denise Zwanziger, Johannes H. Schulte, Jukka Kero, (unknown), Samuel Refetoff, Kurt Werner Schmid, Dagmar Führer, Lars C. Moeller	7
10	Genetically modified mouse models to investigate thyroid development, function and growth 2018 ·Best Practice & Research Clinical Endocrinology & Metabolism ·Christoffer Löf, (unknown), (unknown), Jukka Kero	9
11	Thyrocyte-Specific Dicer1 Deficiency Alters Thyroid Follicular Organization and Prevents Goiter Development 2015 ·Endocrinology ·(unknown), Christoffer Löf, P. Pakarinen, Matti Poutanen, Jukka Kero	15
12	Virus shedding after human rhinovirus infection in children, adults and patients with hypogammaglobulinaemia 2013 ·Clinical Microbiology and Infection ·Ville Peltola, Matti Waris, Leena Kainulainen, Jukka Kero, Olli Ruuskanen	78
13	Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells 2011 ·Journal of Clinical Investigation ·Martina Lukasova, Camille Malaval, Andreas Gille, Jukka Kero, Stefan Offermanns	209
14	(d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G breakdown → 2005 ·Journal of Biological Chemistry ·Andrew K.P. Taggart, Jukka Kero, Xiaodong Gan, Tian‐Quan Cai, Kang Cheng, Marc C. Ippolito, Ning Ren, (unknown), Kenneth Wu, Tsuei-Ju Wu, Lan Jin, Chen Liaw, Ruoping Chen, Jeremy G. Richman, Daniel T. Connolly, Stefan Offermanns, Samuel D. Wright, M. Gerard Waters	529
15	Mode of Delivery and Asthma – Is There a Connection? 2002 ·Pediatric Research ·Jukka Kero, Mika Gissler, Minna‐Maija Grönlund, Pentti Kero, Pertti Koskinen, Elina Hemminki, Erika Isolauri	123
16	Biphasic Action of Prolactin in the Regulation of Murine Leydig Tumor Cell Functions¹ 2001 ·Endocrinology ·Pulak R. Manna, Talal El‐Hefnawy, Jukka Kero, Ilpo Huhtaniemi	47
17	Could TH1 and TH2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: A register study 2001 ·Journal of Allergy and Clinical Immunology ·Jukka Kero, Mika Gissler, Elina Hemminki, Erika Isolauri	185
18	Differential expression and regulation of the retinoblastoma family of proteins during testicular development and spermatogenesis: roles in the control of germ cell proliferation, differentiation and apoptosis 2001 ·Oncogene ·Wei Yan, Jukka Kero, Janne Suominen, Jorma Toppari	35
19	Stem Cell Factor Functions as a Survival Factor for Mature Leydig Cells and a Growth Factor for Precursor Leydig Cells after Ethylene Dimethane Sulfonate Treatment: Implication of a Role of the Stem Cell Factor/c-Kit System in Leydig Cell Development 2000 ·Developmental Biology ·Wei Yan, Jukka Kero, Ilpo Huhtaniemi, Jorma Toppari	78
20	The use of problem-based learning in dealing with cultural minority groups 1997 ·Patient Education and Counseling ·Ansa Ojanlatva, (unknown), (unknown), Antero Horte, (unknown), Jukka Kero, (unknown), Milja Möttönen, Antti Saraste, Tia Turunen	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact